America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

In the U.S. today, frontline cancer treatments are being rationed. ERs are short on sedatives. Amoxicillin—one of the most prescribed antibiotics in the country—has been in critical shortage. These are not temporary disruptions. They reflect a structural breakdown caused by the erosion of America’s pharmaceutical manufacturing base and a decades-long surge in generic drug imports.

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

The American pharmaceutical supply chain has become dangerously dependent on imports and foreign-controlled supply chains. Over the past 20 years, the country has experienced a skyrocketing rate on pharmaceutical imports and increasing foreign reliance.

Big Ag is Dead Wrong on Trade

Big Ag is Dead Wrong on Trade

Feeding America with abundant, healthy, locally-produced food is as important as any trade or industrial goal. Reinforcing our capacity to feed ourselves makes the nation stronger, safer, and more prosperous, whole the Big Ag status quo blindly follows a globalized model that has left far too many American farms behind.

Why the U.S. Needs President Trump’s Tariffs

On April 2, President Donald Trump took bold and historic action to defend American industry with the announcement of sweeping new tariffs aimed at countering unfair foreign trade practices and reigniting U.S. manufacturing. Dubbed “Liberation Day”, this policy marks the first major step in a new era of economic revitalization—one where the United States refuses to accept the systematic dismantling of its industrial base and begins to chart a path back to true production-led prosperity.

Revenue Impact of Retroactive Duties on U.S. Solar Imports under the 2022-2024 Tariff Moratorium

Revenue Impact of Retroactive Duties on U.S. Solar Imports under the 2022-2024 Tariff Moratorium

In June 2022, the Biden administration introduced a two-year tariff moratorium, temporarily suspending import duties on solar cells and panels from four key Southeast Asian exporting nations—Cambodia, Malaysia, Thailand, and Vietnam.